The FDA also recommends that ... Shelby Knowles/Bloomberg via Getty The weightloss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive ...
which was approved for weightloss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023. Although the new FDA green light doesn’t expand ...
called the FDA’s approval a "promising advancement for the millions of people who suffer from this condition." "Zepbound promotes weightloss and has been shown to reduce apnea events." ...
The Food and Drug Administration on Friday approved ... the FDA's director of the division of pulmonology, allergy and critical care. The FDA said the popular weight-loss drug should be ...